Call Us Today!
(225) 706-8424

Public Reporting

ACO Name and Location

TP-ACO L.L.C.
8550 United Plaza Blvd. Ste 702
Baton Rouge, Louisiana 70809

ACO Primary Contact

Primary Contact Name Mr. John Woods
Primary Contact Phone Number 844-252-5321
Primary Contact Email Address JWoods@TPACsecure.com

Organizational Information

ACO participants:

ACO Participants ACO Participant in Joint Venture
Mayo Medical Clinic N
Nageswara Chunduru N
PRIMARY CARE CLINIC LLC N
TENNESSEE HEALTHCARE PARTNERS, LLC N
David Gboloo N
Madden Medical Clinic, LLC N
Internal Medicine Associates LLC N
J CHRIS BECKMAN MD PLLC N
Family Care of Middle Tennessee N
Mid-State Gastroenterology, PLLC N
Williams Foot Center, PLLC N
Covenant Healthcare for Women PLLC N
T. MICHAEL HELTON N
Murfreesboro Surgical Specialist N
George Hopkins N
GENESYS FAMILY MEDICINE N
DHAR FAMILY MEDICINE, PLLC N
PMA MEDICAL TREATMENT CENTERS, LLC N
Logan Family Medicine, LLC N
Wilkes Enterprises Healing Place Medical Center, LLC N
Stones River Dermatology, PLC N
CAPITAL CITY MEDICAL GROUP, L.L.C. N
DiffineFamilyPractice,PLLC N
Harpeth Family Medicine P.C. N
Middle Tennessee Urology Specialist P.L.L.C. N
Eric Egli N
Wayne Murphy N
Baton Rouge General Physician’s Medical Group, LLC N
SulkowskiFamilyMedicine PLLC N
TotalFamilyHealthcare,LLC N
North General Center Of Medicine N
Ader Benoit, MD N
Tampa Neurology Associates N
Margarita R Cancio MD,PA N
ROSEMAY T. LATORTUE,M.D.,P.A. N
Florida Heart & Vascular Associates, Pl N
Middle Tennessee Plastic Surgery, P.C. N
George Hopkins N
HaroldTAkinMDPC N
Suresh C Saraswat MD, PC N
Middle Tennessee Emergency Physician, PC N
FAMILY HEALTH ASSOCIATES N
JOHN BYRNES N
David E. Ours, MD N
Bruce L Wolf, MD N
GARY SCHWARTZ N
TERESA HUGGINS N
David O Ranz, MD N
Middle Tennessee Ear Nose & Throat,PC N
Path Lab of Middle Tennessee N
Prime Obstetricsgynecology N
The Allergy And Asthma Center N
Nageswara Rao Chunduru N
CHARLES WOLOHON N
ELIZABETH R LAROCHE N
Wayne Murphy MD N
MURFREESBORO FAMILY CARE, P.C. N
Eric Egli N
MIDDLE TENNESSEE FAMILY MEDICINE N
TENNESSEE MEDICINE & PEDIATRICS, PC N
FAMILY PRACTICE PARTNERS, PC N
PETER DICORLETO N
JAMES W GARNER JR MD PC N
Cool Springs Internal Medicine And Pediatrics Clinic, Pllc N
Family Medicine Associates of Blytheville, P.A. N
AMERICA”S FAMILY DOCTORS N
CORY L. CASHMAN, MD N
Stan J. Mays MD, APMC N
The Physicians Care Center N
Ahmed Shanablem M.D., Inc N
Optimal Health Outpatient Clinic N
Thomas P. Melancon MD, LLC N
Family First Medical Clinic N
KIRAN G ZAVERI MD LLC N
Christine L Mills Smith N
Good Health Associates, PLLC N
Infectious Diseases Associates of Baton Rouge,LLC N

 

ACO governing body:

Member Member’s Voting Power Membership Type ACO Participant TIN Legal Business Name/DBA, if Applicable
Last Name First Name Title/Position
Cranor Kenneth MD/Chairman 1 ACO Participant Representative The Physicians Alliance Corporation
Willoughby Joseph Voting Member 1 Medicare Beneficiary Representative N/A
Batie Donnie MD/Voting Member 1 ACO Participant Representative Baton Rouge General Physician’s Medical Group, LLC
Bullock Brad MD/Voting Member 1 ACO Participant Representative Cool Springs Internal Medicine and Pediatrics, PLLC
Carter Dennis MD/Voting Member 1 ACO Participant Representative Family Health Associates
Latortue Rosemay MD/Voting Member 1 ACO Participant Representative Rosemay T. Latortue, M.D., P.A
Murphy Wayne MD/Voting Member 1 ACO Participant Representative Wayne Murphy
Perkins Matt MD/Voting 1 ACO Participant Representative Tennessee Medicine and Pediatrics, PC
Zaveri Kiran MD/Voting Member 1 ACO Participant Representative Kiran G. Zaveri, MD LLC

 

 

 

Key ACO clinical and administrative leadership:

John Woods ACO Executive
Kenneth Cranor Medical Director
Pat Woods Compliance Officer
Kenneth Cranor Quality Assurance/Improvement Officer

 

Associated committees and committee leadership:

Committee Name Committee Leader Name and Position
Stones River Patient Care Committee Dennis Carter, Chairman
Harpeth Patient Care Committee Brad Bullock
   
   

 

Types of ACO participants, or combinations of participants, that formed the ACO:

  • Networks of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

  • Second Agreement Period
    • Performance Year 2016, $2,459,316
  • First Agreement Period
    • Performance Year 2015, $1,662,988
    • Performance Year 2014, $3,133,900
    • Performance Year 2013, $4,721,981

Shared Savings Distribution

  • Second Agreement Period
    • Performance Year 2016
      • Proportion invested in infrastructure: 10%
      • Proportion invested in redesigned care processes/resources: 5%
      • Proportion of distribution to ACO participants: 85%
  • First Agreement Period
    • Performance Year 2015
      • Proportion invested in infrastructure: 10%
      • Proportion invested in redesigned care processes/resources: 5%
      • Proportion of distribution to ACO participants: 85%
    • Performance Year 2014
      • Proportion invested in infrastructure: 10%
      • Proportion invested in redesigned care processes/resources: 5%
      • Proportion of distribution to ACO participants: 85%
    • Performance Year 2013
      • Proportion invested in infrastructure: 10%
      • Proportion invested in redesigned care processes/resources: 5%
      • Proportion of distribution to ACO participants: 85%

Quality Performance Results

2016 Quality Performance Results:

ACO# Measure Name Rate ACO Mean
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information 84.75 79.9
ACO-2 CAHPS: How Well Your Providers Communicate 93.27 92.63
ACO-3 CAHPS: Patients’ Rating of Provider 91.55 91.93
ACO-4 CAHPS: Access to Specialists 82.54 83.52
ACO-5 CAHPS: Health Promotion and Education 63.9 60
ACO-6 CAHPS: Shared Decision Making 75.26 75.28
ACO-7 CAHPS: Health Status/Functional Status 71.28 71.82
ACO-34 CAHPS: Stewardship of Patient Resources 31.87 27.52
ACO-8 Risk-Standardized, All Condition Readmission 15.11 14.7
ACO-35 Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM) 19.45 18.17
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes 59.83 53.2
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure 78.87 75.23
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 60.96 59.81
ACO-9 Ambulatory Sensitive Conditions Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) 14.04 9.27
ACO-10 Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8 ) 16.13 14.53
ACO-11 Percent of PCPs who Successfully Meet Meaningful Use Requirements 59.26 82.72
ACO-39 Documentation of Current Medications in the Medical Record 84.81 87.54
ACO-13 Falls: Screening for Future Fall Risk 83.96 64.04
ACO-14 Preventive Care and Screening: Influenza Immunization 66.57 68.32
ACO-15 Pneumonia Vaccination Status for Older Adults 67.54 69.21
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow Up 88.55 74.45
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 91.63 90.98
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 81.05 53.63
ACO-19 Colorectal Cancer Screening 63.4 61.52
ACO-20 Breast Cancer Screening 73.03 67.61
ACO-21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-up Documented 76.44 76.84
ACO-42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 45.07 77.72
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control 31.72 18.24
ACO-41 Diabetes: Eye Exam 44.37 44.94
ACO-28 Hypertension (HTN): Controlling High Blood Pressure 65.57 70.52
ACO-30 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic 62.59 85.05
ACO-31 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) 32.06 88.67
ACO-33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) 48.9 79.67

 

 

 

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.

 

Note: In the Quality Performance Results file(s) above, search for “TP-ACO L.L.C.” to view the quality performance results. This ACO can also be found by using the ACO ID A74604 in the public use files on data.cms.gov.

Payment Rule Waivers

  • No, our ACO does not use the SNF 3-Day Rule Waiver.